Post-interventional adverse event risk by vascular access site among patients with acute coronary syndrome in Japan: observational analysis with a national registry J-PCI database
- 7 March 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cardiovascular Intervention and Therapeutics
- Vol. 34 (4), 297-304
- https://doi.org/10.1007/s12928-019-00582-0
Abstract
This study evaluated whether radial access intervention had a lower risk of post-treatment adverse events in acute coronary syndrome (ACS) even in Japan where the use of a strong antithrombotic regimen was not approved. We retrospectively analyzed a large nation-wide registry in Japan to compare the incidence of post-treatment adverse events according to the types of vessel access (trans-radial; TRI vs. trans-femoral; TFI) among ACS cases (n = 76,835; 43,288 TRI group and 33,547 TFI group). Primary outcome was a composite of in-hospital death, myocardial infarction associated with percutaneous coronary intervention, bleeding complication requiring transfusion, and stent thrombosis during in-hospital stay. Propensity score matching (PS) and instrumental variable (IV) analyses were used to account for treatment selection. The incidence of post-treatment adverse events was lower in the TRI group by 0.95% compared to the TFI group with PS (p < 0.001) and by 0.34% with IV (p = 0.127). A significantly lower risk for access site bleeding was observed by 0.34% with PS (p < 0.001) and by 0.53% with IV (p < 0.001). Radial access was related to a significantly lower risk for access site bleeding compared with femoral access, even without strong antithrombotic drugs for ACS in Japan, and may also relate to lower risk for a wider set of post-treatment adverse events.Keywords
This publication has 26 references indexed in Scilit:
- Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trialThe Lancet, 2015
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsThe New England Journal of Medicine, 2014
- Transradial Versus Transfemoral Percutaneous Coronary Intervention in Acute Coronary SyndromesJACC: Cardiovascular Interventions, 2013
- Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trialsHeart, 2011
- Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2011
- New P2Y12Inhibitors Versus Clopidogrel in Percutaneous Coronary Intervention: A Meta-AnalysisJournal of the American College of Cardiology, 2010
- Gastrointestinal Bleeding in Patients With Acute Coronary Syndromes: Incidence, Predictors, and Clinical Implications: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TrialJournal of the American College of Cardiology, 2009
- Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention: A Report From the National Cardiovascular Data RegistryКАРДИОЛОГИЯ УЗБЕКИСТАНА, 2008
- Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesEuropean Heart Journal, 2008
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingThe New England Journal of Medicine, 1998